Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Oestrogens are key for bone growth during puberty in both boys and girls.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Finasteride improves hair loss in women with hyperandrogenism.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Certain hormone treatments can improve acne and related conditions in women.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Understanding chaos and control mechanisms in disease can improve diagnosis and prediction in medicine.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.